In addition, replacing endogenous OCT4 with OCT4 S236D reduced tumor growth and a population of cells positive for SOX2, one of the undifferentiation markers, in mouse xenograft experiments in vivo (Figure 4). The gene discussed is POU5F1; the disease is neoplasm.